Trade ERAS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Erasca, Inc. (ERAS) is trading at US$15.78, down 6.07% today as of Nov 12, 16:00 EST. The company has a market capitalisation of US$6.17B. Over the past 52 weeks, ERAS has traded between US$2.46 and US$24.28. On Syfe you can trade ERAS with $0 commission and add it to your watchlist.
| Previous close | US$16.80 |
|---|---|
| Market cap | US$6.17B |
| 52-week range | US$2.46 – US$24.28 |
| Volume | 4.85M |
| Exchange | US |
Erasca, Inc.
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
Year: 2021
Erasca, Inc. (ERAS) stock is trading at US$15.78, -6.07% from the previous close of US$16.80.
The market cap for Erasca, Inc. (ERAS) stock is approximately US$6.17B.
The 52-week high for Erasca, Inc. (ERAS) stock is US$24.28.
The 52-week low for Erasca, Inc. (ERAS) stock is US$2.46.
Erasca, Inc. (ERAS) does not currently pay a dividend.
Stay on top of ERAS
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
